Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

IPO, Figma

Seeking Alpha on MSN · 2d
Figma sets price range for NYSE IPO
Design software company Figma is planning to offer about 12.47M class A common shares priced in the range of $25 to $28 per share in its IPO on the New York Stock Exchange. The San Francisco-based company said in a regulatory filing on Monday that selling stockholders are offering about 24.
Cryptopolitan on MSN · 1d
Figma looks to raise $1 billion at $16 billion valuation in IPO filing
The San Francisco-based design software company filed for an initial public offering (IPO) with the US Securities and Exchange Commission (SEC) to raise up to $1 billion and secure a valuation of roughly $16.
Financial Times · 2d
Figma seeks $16bn value in test of US tech IPO market
Design software maker’s offering being followed in Silicon Valley for signs the market is ready for more tech listings
1don MSN
Figma IPO launch: Stock aims for $16.4 Billion valuation in NYSE debut, signals tech listing comeback
Figma, a cloud-based design platform, is set to debut on the New York Stock Exchange with an IPO aiming for a $16.4 billion ...
Blockonomi
1d
Figma Reveals $70M Bitcoin ETF Stake Ahead of IPO, Adds Blockchain Stock Option
Figma disclosed a $70M Bitcoin ETF position and blockchain stock plans in its IPO filing, signaling crypto adoption.
2d
Figma IPO could value design software maker at $16 billion
Figma disclosed preliminary results for the second quarter showing revenue growth between 39% and 41% year over year.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy